Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection

BACKGROUND: Interferon and ribavirin therapy for chronic hepatitis C virus (HCV) infection yields sustained virological response (SVR) rates of 50–80%. Several factors such as non-1 genotype, beneficial IL28B genetic variants, low baseline IP-10, and the functionality of HCV-specific T cells predict...

詳細記述

保存先:
書誌詳細
主要な著者: Söderholm, Jonas, Waldenström, Jesper, Askarieh, Galia, Pilli, Massimo, Bochud, Pierre-Yves, Negro, Francesco, Pawlotsky, Jean-Michel, Zeuzem, Stefan, Ferrari, Carlo, Norkrans, Gunnar, Wejstål, Rune, Westin, Johan, Neumann, Avidan U., Haagmans, Bart L., Lindh, Magnus, Missale, Gabriele, Hellstrand, Kristoffer, Lagging, Martin
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2013
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3577643/
https://ncbi.nlm.nih.gov/pubmed/23437290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0056991
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料